BioRestorative Therapies, Inc. 

NY

  SEC # 1505497

        

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

Registrant
 SEC-Registered:  11/12/10   —   First EDGAR Filing:  11/16/10   –   Last Filing:  4/19/24 

Business Address      On:  4/19/24       [ Map ]		Mailing Address      On:  4/19/24       [ Map ]
40 Marcus Drive Melville, New York  11747 U.S.A.

Phone #		Organized In		Fiscal-Year End		IRS #		SEC CIK		SEC File #
+1 631-760-8100		Nevada, U.S.A.		12/31/yy		30-1341024		0001505497		001-37603

Market: Symbol:  Nasdaq: BRTX

— Common Stock

In a Major Index:	NASDAQ Composite

Industry Classification
ICB – Industry Classification Benchmark:               Industry    →       Subsector      Financials Diversified Financial Services   SIC:     Code      U.S. Industry      Through      Source      Filings-Review Office 8090 Miscellaneous Health and Allied Services, Not Elsewhere Classified, et al. 2024 SEC Office of Industrial Applications & Services

        

Management
Director   In   NY   Alstodt Lance 2020-2024   FL   Silva Francisco 2020-2024   TX   Kukekov Nickolay V. 2021-2024   MN   Rosa David A 2021-2024   CA   Williams Patrick F. 2021-2024 ↓List Pre-2020 Directors				Officer  Since  Most-Recent Title   In   TX   Kristal Robert Eugene 2021 Chief Financial Officer 2024   NY   Alstodt Lance 2018 President, CEO, COB 2024   NY   Paccasassi Robert 2018 VP, QA & Reg Compliance 2024   FL   Silva Francisco 2011 VP of Research & Development 2024 ↓List Pre-2020 Officers

        

        

        

        

Securities
Market:  Symbol    Description        (Prices) (Type — Name)   Nasdaq:  BRTX   Common Stock — COM NPV _________  Symbol source:  SEC  As of:  4/25/24		CUSIP, CINS or PPN       Description ← Symbol   Issuer Issue (Class or re: Filing — Name)      To 2024:   090655 090655·13·5     re: ‘10-K’ – 3/30/22 090655·40·8     Stock 090655·60·6     Common New — COM NPV ← BRTX _________  Classes source:  Form 13F Filings that list Section 13(f) Securities